CFAR Members Helen Gerns and Judd Walson are featured in a UW News article publicizing their research about integration of deworming interventions for children into HIV care.
The U.S. Food and Drug Administration decided today, July 16, to approve the use of an HIV treatment drug for reducing the risk of acquiring HIV.
Now, as HIV/AIDS researchers worldwide seem to be moving closer to a possible HIV vaccine, Hu has received a vote of confidence from the Bill & Melinda Gates Foundation for his contributions to the field.
By Keegan Hamilton
By Pam Belluck; posted 10/03/2011; 5:05 pm.
From PC Magazine; Leslie Horn; 9/19/2011; 10:42am EST
Revalesio, a pioneering biotechnology company based in Tacoma, recently signed an 18-month contract with the Katze lab at the UW to bring hope to sufferers of influenza, HIV and hepatitis C.
June 10, 2011 (New York) – The Global Forum on MSM & HIV (MSMGF) welcomes the progress represented in the new 2011 United Nations Political Declaration on HIV and AIDS, expected to be formally
Had the last word: "It's because of who's affected. Cholera is ignored because it's a disease of the poorest of the poor."
Treating herpes also buys time for HIV, doctors find. text about article in UK Independent.text about article in UK Independent.
text about article in UK Independent
The Center for AIDS Research is an NIH-funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers:NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, NIGMS, NIDDK, FIC, and OAR
Site Map | Contact | CFAR Interactive Map | Donate | Acknowledge CFAR | UW Department of Global Health | UW Center for AIDS and STD | Site by Fuse IQ